Why the study?
Does telmisartan suppress cell proliferation and PSA expression in prostate cancer cells?
Population
Prostate cancer cells (in vitro)
Design
Preclinical
Authors
Loading...
Telmisartan should not alter prostate cancer care; leaves open anti-androgenic effects for in vivo and clinical testing.
Does telmisartan suppress cell proliferation and PSA expression in prostate cancer cells?
Telmisartan demonstrates potential anti-androgenic effects by inhibiting prostate cancer cell proliferation and PSA expression in vitro.
Ishiguro et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: